Glioblastoma mesenchymal subtype enhances antioxidant defence to reduce susceptibility to ferroptosis

Nature·Sep 5

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Research on glioblastoma is exploring the role of ferroptosis, a form of cell death, in the disease. The glioblastoma mesenchymal subtype appears to have enhanced antioxidant defenses that reduce its susceptibility to ferroptosis. Studies are investigating various mechanisms and potential therapeutic strategies to target glioblastoma, including metabolic reprogramming and ferroptosis induction.

Full coverage

Ferroptosis and metabolic reprogramming in the immunosuppressive microenvironment of glioblastoma: emerging mechanisms and novel strategies

Frontiers·Mar 9

Harnessing ferroptosis to transform glioblastoma therapy and surmount treatment resistance | Cell Death Discovery

Nature·Oct 7

Dual inhibition of xCT and GGCT induces ferroptosis in glioblastoma cells by depleting cysteine and disrupting redox homeostasis

Nature·Apr 15

Neural stem cells fate under neuroinflammatory conditions and oxidative stress response

Frontiers·Dec 3

Ioning out glioblastoma: ferroptosis mechanisms and therapeutic frontiers

Nature·Aug 26

Targeting metabolic reprogramming in glioblastoma as a new strategy to overcome therapy resistance

Frontiers·Feb 25

Ferroptosis inhibits biological behaviors of glioma cells by downregulating Galectin-9 transcriptional level via extracellular Acetyl-HMGB1

Nature·Mar 29

Purine metabolism rewiring improves glioblastoma susceptibility to temozolomide treatment | Cell Death & Disease

Nature·Apr 24

View original report at Nature ↗

Fetching the latest headlines…